Genomic
Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.0001 per share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 17th Floor
New
York, NY 10021
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices
and
Communications)
|
||||
March
9, 2007
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 37244C101
|
Page
2
of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian
C. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
o
(b) x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
o | |||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
2,941,272
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
2,941,272
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,941,272
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.0%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 37244C101
|
Page
3
of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix
J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a) o
(b)
x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
o | |||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
2,941,272
|
|||
8
|
SHARED
VOTING POWER
2,941,272
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
2,941,272
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,941,272
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.0%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Name
|
Business
Address
|
Present
Principal Occupation
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Percent
of class
|
|||||||
Name
|
Number
of Shares
|
Outstanding
|
|||||
Baker
Bros. Investments, L.P.
|
173,897
|
0.7
|
%
|
||||
Baker
Bros. Investments II, L.P.
|
16,444
|
0.1
|
%
|
||||
Baker
Biotech Fund I, L.P.
|
606,709
|
2.4
|
%
|
||||
Baker
Brothers Life Sciences, L.P.
|
1,738,099
|
7.1
|
%
|
||||
14159,
L.P.
|
38,467
|
0.2
|
%
|
||||
Baker/Tisch
Investments, L.P.
|
193,759
|
0.8
|
%
|
||||
FBB
Associates
|
173,897
|
0.7
|
%
|
||||
Total
|
2,941,272
|
12.0
|
%
|
Name
|
Date
|
Number
of Shares
|
Transaction
|
Price/
Share
|
14159,
L.P.
|
3/1/2007
|
1,123
|
Purchase
|
18.2041
|
Baker
Bros. Investments II, L.P.
|
3/1/2007
|
78
|
Purchase
|
18.2041
|
Baker
Biotech Fund I, L.P.
|
3/1/2007
|
13,004
|
Purchase
|
18.2041
|
Baker
Brothers Life Sciences, L.P.
|
3/1/2007
|
35,170
|
Purchase
|
18.2041
|
Baker/
Tisch Investments, L.P.
|
3/1/2007
|
725
|
Purchase
|
18.2041
|
14159,
L.P.
|
3/1/2007
|
8
|
Purchase
|
17.9
|
Baker
Biotech Fund I, L.P.
|
3/1/2007
|
80
|
Purchase
|
17.9
|
Baker
Brothers Life Sciences, L.P.
|
3/1/2007
|
216
|
Purchase
|
17.9
|
Baker/
Tisch Investments, L.P.
|
3/1/2007
|
4
|
Purchase
|
17.9
|
14159,
L.P.
|
3/1/2007
|
335
|
Purchase
|
17.77
|
Baker
Bros. Investments II, L.P.
|
3/1/2007
|
24
|
Purchase
|
17.77
|
Baker
Biotech Fund I, L.P.
|
3/1/2007
|
3,899
|
Purchase
|
17.77
|
Baker
Brothers Life Sciences, L.P.
|
3/1/2007
|
10,543
|
Purchase
|
17.77
|
Baker/
Tisch Investments, L.P.
|
3/1/2007
|
199
|
Purchase
|
17.77
|
14159,
L.P.
|
3/2/2007
|
241
|
Purchase
|
18.0242
|
Baker
Bros. Investments II, L.P.
|
3/2/2007
|
17
|
Purchase
|
18.0242
|
Baker
Biotech Fund I, L.P.
|
3/2/2007
|
2,812
|
Purchase
|
18.0242
|
Baker
Brothers Life Sciences, L.P.
|
3/2/2007
|
7,604
|
Purchase
|
18.0242
|
Baker/
Tisch Investments, L.P.
|
3/2/2007
|
144
|
Purchase
|
18.0242
|
14159,
L.P.
|
3/9/2007
|
1
|
Purchase
|
18.4400
|
Baker
Biotech Fund I, L.P.
|
3/9/2007
|
4
|
Purchase
|
18.4400
|
Baker
Brothers Life Sciences, L.P.
|
3/9/2007
|
12
|
Purchase
|
18.4400
|
14159,
L.P.
|
3/9/2007
|
5,374
|
Purchase
|
18.2809
|
Baker
Bros. Investments II, L.P.
|
3/9/2007
|
376
|
Purchase
|
18.2809
|
Baker
Biotech Fund I, L.P.
|
3/9/2007
|
62,321
|
Purchase
|
18.2809
|
Baker
Brothers Life Sciences, L.P.
|
3/9/2007
|
168,548
|
Purchase
|
18.2809
|
Baker/
Tisch Investments, L.P.
|
3/9/2007
|
3,181
|
Purchase
|
18.2809
|
By:
|
/s/
Julian C. Baker
|
|
Julian
C. Baker
|
||
By:
|
/s/
Felix J. Baker
|
|
Felix
J. Baker
|
By:
|
/s/
Julian C. Baker
|
|
|
Julian
C. Baker
|
|
By:
|
/s/
Felix J. Baker
|
|
|
Felix
J. Baker
|